From patient to advocate. Helping to shape what’s next.
Meet Jimi Olaghere, Patient in Residence and Advisor at NV Therapeutics.
Jimi received a life-changing CRISPR gene therapy for Sickle Cell Disease that transformed his life. Now, he brings his remarkable perspective to NV Therapeutics, helping connect the development of next-generation genetic medicines with the patients who stand to benefit from them.
Watch our conversation with Jimi as he shares his remarkable journey, reflects on the impact of gene therapy, and explores how NV Therapeutics is advancing the next generation of genetic medicines.
At NV Therapeutics, we believe the people who stand to benefit from the next generation of genetic medicines should have a voice in shaping their development.
Jimi’s journey is a powerful reminder of why we do what we do - and of the tremendous opportunity to make transformative therapies available to more patients.
As our Patient in Residence, Jimi works alongside our scientists and leadership team, sharing his experiences, contributing a patient perspective to our research, and helping bridge the gap between scientific innovation and the people it is intended to serve.
During his last month-long residence in our research facility, Jimi went beyond observing the science. He rolled up his sleeves, joined our scientists at the bench, and performed CRISPR experiments himself - experiencing firsthand the technologies that are shaping the future of genetic medicine.
Read an interview with Jimi and NV Therapeutics about his Patient in Residence role and his drive to create meaningful patient engagement that can shape the development of more effective, accessible, and affordable gene therapies:
Read the San Francisco Business Times feature → (Complimentary access)